Chart calendar Roivant Sciences Ltd.

8826d3068f11a1211ffb2a8ef281ca5.vpGe1jkiZHeIQEXqBTkwyr_Lr7XtF7LCViPlMAx7Y6U.ydWqnGxqISjtGDSQbnEJ59WU7P6MdfnvMXSBZHUCTtbwpNW-XmY-BdIhDA~39cc90a55f4b78fd727f55304269be6d

Upcoming events on Roivant Sciences Ltd.

2024-08-11 Q1 2024 Earnings Release (Projected)
2024-11-10 Q2 2024 Earnings Release (Projected)
2025-02-16 Q3 2024 Earnings Release (Projected)
2025-06-24 Q4 2024 Earnings Release (Projected)

Past events on Roivant Sciences Ltd.

2024-06-10 08:40 Goldman Sachs Global Healthcare Conference
2024-06-05 11:30 Jefferies Global Healthcare Conference
2024-05-30 08:00 Q4 2023 Earnings Call
2024-05-30 07:00 Q4 2023 Earnings Release
2024-05-20 09:00 H.C. Wainwright BioConnect Investor Conference
2024-04-07 Investor Meeting
2024-04-02 08:00 NEPTUNE Phase 2 Study Results Call
2024-03-11 13:20 Leerink Partners Global Biopharma Conference
2024-02-13 08:00 Q3 2023 Earnings Call
2024-02-13 07:00 Q3 2023 Earnings Release
2024-02-07 14:30 Guggenheim Healthcare Talks Biotechnology Conference
2024-01-08 17:15 JPMorgan Healthcare Conference
2023-11-30 11:00 Piper Sandler Healthcare Conference
2023-11-29 12:55 Evercore ISI HealthCONx Conference
2023-11-15 08:30 Jefferies London Healthcare Conference
2023-11-13 08:00 Q2 2023 Earnings Call
2023-11-13 07:00 Q2 2023 Earnings Release
2023-11-07 16:30 Guggenheim Inflammation, Neurology, & Immunology Conference
2023-10-23 08:00 Acquisition of Telavant Holdings, Inc by Roivant Sciences Ltd Call
2023-09-27 11:30 Cantor Global Healthcare Conference

Annual results

Fiscal PeriodMarch 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
55,3
52,6
5.08%
61,3
52,3
17.2%
125
662
-81.14%

149


262


632

EBITDA
Million USD
Released
Forecast
Spread
-1 346
-1 304
-3.16%
-1 156
-1 190
2.8%
-1 084
-1 071
-1.28%

-1 127


-1 069


0,00

EBIT
Million USD
Released
Forecast
Spread
-1 352
-1 181
-14.47%
-1 175
-1 170
-0.41%
-1 106
1 608
-168.79%

-1 065


-1 048


-601

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-924
-864
-6.97%
-1 225
-1 313
6.71%
4 253
4 176
1.87%

-977


-954


-429

Net income
Million USD
Released
Forecast
Spread
-845
-740
-14.23%
-1 009
-1 216
16.99%
4 349
4 261
2.07%

-853


-829


-367

EPS
USD
Released
Forecast
Spread
-1,26
-1,24
-1.34%
-1,42
-1,71
17.02%
5,23
5,18
0.99%

-1,14


-1,18


-0,55

Announcement Date28/06/2228/06/2330/05/24-

Quarterly results

Fiscal PeriodMarch 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
4,32
7,18
-39.83%
12,5
5,70
119.85%
17,1
14,8
15.34%
27,4
18,2
50.4%
21,6
24,5
-11.69%
37,1
27,1
36.82%
37,1
29,8
24.53%
28,9
30,9
-6.51%

29,7


32,9


36,1


55,0


46,0


58,6


67,9


64,5

EBITDA
Million USD
Released
Forecast
Spread



-281
-291
3.52%
-378
-291
-29.92%
-228
-288
20.76%
-271
-284
4.56%
-271
-264
-2.5%
-282
-265
-6.51%
-261
-240
-8.52%

-281


-292


-307


-329













EBIT
Million USD
Released
Forecast
Spread
-282
-250
-13.14%
-281
-293
4.13%
-378
-309
-22.4%
-234
-285
17.76%
-276
-258
-7.28%
-276
-257
-7.63%
5 061
-267
1992.11%
-266
-285
6.65%

-261


-265


-271


-269


-248


-252


-256


-256

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-350
-243
-43.86%
-314
-299
-5.05%
-382
-320
-19.46%
-179
-309
41.96%
-326
-249
-30.78%
-327
-249
-31.46%
5 098
-279
1929.33%
-191
-276
30.57%

-235


-244


-253


-250













Net income
Million USD
Released
Forecast
Spread
-332
-222
-49.66%
-292
-280
-4.2%
-352
-294
-19.63%
-33,6
-280
88.01%
-292
-235
-24.3%
-304
-225
-34.98%
5 096
-255
2094.89%
-151
-248
39.06%

-207


-215


-223


-222













EPS
USD
Released
Forecast
Spread
-0,48
-0,32
-48.02%
-0,42
-0,41
-1.76%
-0,49
-0,40
-22.69%
-0,05
-0,38
86.8%
-0,38
-0,31
-24.18%
-0,40
-0,31
-30.84%
6,03
0,49
1140.1%
-0,19
-0,30
35.75%

-0,26


-0,28


-0,30


-0,30


-0,22


-0,20


-0,21


-0,23

Announcement Date15/08/2214/11/2213/02/2328/06/2314/08/2313/11/2313/02/2430/05/24--------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ROIV Stock
  4. Calendar Roivant Sciences Ltd.